期刊文献+

基于剂量组学预测肺癌患者放射性肺炎发生的研究 被引量:2

Dosiomics-based prediction of incidence of radiation pneumonitis in lung cancer patients
原文传递
导出
摘要 目的探讨剂量组学在预测肺癌根治性放疗患者放射性肺炎发生中的应用潜能。方法回顾性收集行根治性放疗的314例肺癌患者的临床资料、放疗剂量文件、定位及随访CT图像,根据临床资料及影像学随访资料对放射性肺炎进行分级,提取全肺的剂量组学特征,构建机器学习模型。应用1000次自助抽样法(bootstrap)的最小绝对值收敛和选择算子嵌套逻辑回归(LASSO-LR)及1000次bootstrap的赤池信息量准则(AIC)向后法筛选与放射性肺炎相关的剂量组学特征,随机按照7∶3划分为训练集及验证集,应用逻辑回归建立预测模型,并应用ROC曲线及校正曲线评价模型的性能。结果共提取120个剂量组学特征,经LASSO-LR降维筛选得到12个特征进入“特征池”,再经过AIC向后法筛选,最终筛选出6个剂量组学特征进行模型构建,训练集AUC为0.77(95%CI为0.65~0.87),独立验证集AUC为0.72(95%CI为0.64~0.81)。结论利用剂量组学建立的预测模型具有预测放射性肺炎发生的潜力,但仍需继续纳入多中心数据及前瞻性数据进一步挖掘剂量组学的应用潜能。 Objective To explore the potential of dosiomics in predicting the incidence of radiation pneumonitis by extracting dosiomic features of definitive radiotherapy for lung cancer,and building a machine learning model.Methods The clinical data,dose files of radiotherapy,planning CT and follow-up CT of 314 patients with lung cancer undergoing definitive radiotherapy were collected retrospectively.According to the clinical data and follow-up CT,the radiation pneumonia was graded,and the dosiomic features of the whole lung were extracted to establish a machine learning model.Dosiomic features associated with radiation pneumonia by LASSO-LR with 1000 bootstrap and AIC backward method with 1000 bootstraps were selected.Training cohort and validation cohort were randomly divided on the basis of 7:3.Logistic regression was used to establish the prediction model,and ROC curve and calibration curve were adopted to evaluate the performance of the model.Results A total of 120 dosiomic features were extracted.After LASSO-LR dimensionality reduction,12 features were selected into the"feature pool".After AIC,6 dosiomic features were finally selected for model construction.The AUC of training cohort was 0.77(95%CI:0.65 to 0.87),and the AUC of validation cohort was 0.72(95%CI:0.64 to 0.81).Conclusion The dosiomics prediction model has the potential to predict the incidence of radiation pneumonia,but it still needs to include multicenter data and prospective data.
作者 闫萌 张臻 于佳琦 王伟 王清鑫 赵路军 Meng Yan;Zhen Zhang;Jiaqi Yu;Wei Wang;Qingxin Wang;Lujun Zhao(Department of Radiation Oncology,Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy,Tianjin/Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Department of Radiation Oncology(MAASTRO),GROW School for Oncology and Reproduction,Maastricht University Medical Centre+,Maastricht 6229ET,The Netherlands)
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2022年第8期698-703,共6页 Chinese Journal of Radiation Oncology
基金 国家自然科学基金(81872472)。
关键词 肺肿瘤 剂量组学 放射性肺炎 机器学习 Lung neoplasms Dosiomics Radiation pneumonitis Machine learning
  • 相关文献

参考文献3

二级参考文献38

  • 1于金明,郑爱青,于甬华,王学涛,袁双虎,韩大力,李昆海.大分割立体适形放疗非小细胞肺癌的临床分析[J].中华放射肿瘤学杂志,2005,14(5):415-418. 被引量:19
  • 2Clade L, Perol D, Ginestet C,et al. A prospective on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol,2004,71 : 175-181.
  • 3Schild SE, Stella PJ, Geyer SM, et al. The outcome of combined modality therapy for stage Ⅲ non-small cell lung cancer in the elderly. J Clin Oncol,2003,21 : 3201-3206.
  • 4Inoue A,Kunitoh H,Sekine I, et al. Radiation pneumonitis in lung cancer patients:a retrospective study of risk factors and the longterm prognosis. Int J Radiat Oncol Biol Phys ,2001,49 :649-655.
  • 5Rancati T, Ceresoli GL, Gagliardi G,et al. Factors predicting radiation pneumonitis in lung cancer patients:a retrospective study. Radiother Oncol,2003 ,67 :275-283.
  • 6Yamada M,Kudoh S,Hirata K,et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer, 1998, 34 : 71-75.
  • 7Robnett TJ,Machtay M,Vines EF,et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys,2000,48: 89- 94.
  • 8Roach M 3rd, Gandara DR, You HS, et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognoetic factors. J Clin Oncol, 1995,13:2606-2612.
  • 9Schaake-Koning C,van den Bogaert W,Dalesio O,et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med, 1992,326 : 524-530.
  • 10Jeremic BJ Jr, Shibamoto Y, Acimovic L, et al. Hypeffractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage Ⅲ non-small cell lung cancer: a randomized study. J Clin Oncol,1996,326: 524-530.

共引文献17

同被引文献4

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部